Registration of share capital reduction by reduction of the par value of shares in IDEX Biometrics - 25 April 2025

6 hours ago 6
Suniway Group of Companies Inc.

Upgrade to High-Speed Internet for only ₱1499/month!

Enjoy up to 100 Mbps fiber broadband, perfect for browsing, streaming, and gaming.

Visit Suniway.ph to learn

Scroll Up

Reference is made to the share capital reduction in IDEX Biometrics ASA (the "Company”) resolved by the extraordinary general meeting on 11 April 2025, agenda item 3.

The share capital reduction by reduction of the par value of the shares in the Company has been registered.

Following the registration, the Company's share capital is NOK 8,315,942.32 divided into 831,594,232 shares, each with a nominal value of NOK 0.01.

For further information contact:

Marianne Bøe, Head of Investor Relations, Tel: +47 91800186

Get the latest news
delivered to your inbox

Sign up for The Manila Times newsletters

By signing up with an email address, I acknowledge that I have read and agree to the Terms of Service and Privacy Policy.

Kristian Flaten, CFO, Tel: +47 95092322

E-mail: [email protected]

About IDEX Biometrics:

IDEX Biometrics ASA ( IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market. For more information, visit www.idexbiometrics.com .

About this notice:

This notice was published by Kristian Flaten, CFO, 25 April 2025 at 11:30 CET on behalf of IDEX Biometrics ASA.  This information is subject to the disclosure requirements pursuant to the Norwegian Securities Trading Act section 5-12.

This website uses cookies. By continuing to browse the website, you are agreeing to our use of cookies. Read More.

Read Entire Article